The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship of time to testosterone (T) and PSA rises during the first “off treatment” interval (1OFF) of intermittent androgen deprivation (IAD) with time to castration resistance (CRPC) and prostate cancer mortality (PCM) in men with biochemical relapse (BR).
Evan Y. Yu
No relevant relationships to disclose
Kevin F Kuo
No relevant relationships to disclose
Rachel Hunter-Merrill
No relevant relationships to disclose
Roman Gulati
No relevant relationships to disclose
Suzanne P Hall
No relevant relationships to disclose
Teresa E Gambol
No relevant relationships to disclose
Ruth D Etzioni
No relevant relationships to disclose
Celestia S. Higano
No relevant relationships to disclose